HUT64213A - Process for producing new medicament forms containing inoizable materials of medical affect - Google Patents
Process for producing new medicament forms containing inoizable materials of medical affectInfo
- Publication number
- HUT64213A HUT64213A HU9301671A HU167193A HUT64213A HU T64213 A HUT64213 A HU T64213A HU 9301671 A HU9301671 A HU 9301671A HU 167193 A HU167193 A HU 167193A HU T64213 A HUT64213 A HU T64213A
- Authority
- HU
- Hungary
- Prior art keywords
- inoizable
- medical
- affect
- materials
- forms containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9003903A SE9003903D0 (sv) | 1990-12-07 | 1990-12-07 | New pharmaceutical formulations |
| PCT/SE1991/000814 WO1992010171A1 (en) | 1990-12-07 | 1991-12-03 | New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9301671D0 HU9301671D0 (en) | 1993-09-28 |
| HUT64213A true HUT64213A (en) | 1993-12-28 |
| HU218661B HU218661B (hu) | 2000-10-28 |
Family
ID=20381122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9301671A HU218661B (hu) | 1990-12-07 | 1991-12-03 | Eljárás gyógyászatilag hatásos ionos hatóanyag és ioncserélő műgyanta komplexét tartalmazó gyógyszerformák előállítására |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5707656A (hu) |
| EP (1) | EP0560816B1 (hu) |
| JP (1) | JP3276956B2 (hu) |
| AT (1) | ATE444737T1 (hu) |
| AU (1) | AU656346B2 (hu) |
| CA (1) | CA2097176C (hu) |
| DE (1) | DE69133623D1 (hu) |
| EE (1) | EE03105B1 (hu) |
| FI (1) | FI932553A0 (hu) |
| HU (1) | HU218661B (hu) |
| IE (1) | IE914136A1 (hu) |
| IS (1) | IS1749B (hu) |
| NO (1) | NO305536B1 (hu) |
| PT (1) | PT99720B (hu) |
| SE (1) | SE9003903D0 (hu) |
| WO (1) | WO1992010171A1 (hu) |
| YU (1) | YU186791A (hu) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT946145E (pt) * | 1996-12-20 | 2008-10-17 | Mcneil Ppc Inc | Fármacos antitússicos libertados por resinas de troca iónica |
| US20030118641A1 (en) * | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| JP2003522127A (ja) * | 1999-07-29 | 2003-07-22 | ロクセニ ラボラトリーズ インコーポレイテッド | オピオイド徐放性製剤 |
| DE60219478T2 (de) * | 2001-07-06 | 2008-01-03 | Endo Pharmaceuticals Inc. | Orale gabe von 6-hydroxy-oxymorphon als analgetikum |
| EP1429728A1 (en) * | 2001-08-29 | 2004-06-23 | SRL Technologies, Inc. | Sustained release preparations |
| EP1499295A4 (en) * | 2002-04-05 | 2006-04-05 | Penwest Pharmaceuticals Co | EXTENDED RELEASE METOPROLOL FORMULATIONS |
| US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| JP2006296511A (ja) * | 2005-04-15 | 2006-11-02 | Transcutaneous Technologies Inc | 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ |
| JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
| EP1905433A1 (en) * | 2005-07-15 | 2008-04-02 | Transcu Ltd. | Percutaneous absorption patch with application position indicating function, and iontophoresis device |
| JP2007037868A (ja) * | 2005-08-05 | 2007-02-15 | Transcutaneous Technologies Inc | 経皮投与装置及びその制御方法 |
| US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
| US20070060860A1 (en) * | 2005-08-18 | 2007-03-15 | Transcutaneous Technologies Inc. | Iontophoresis device |
| JPWO2007026671A1 (ja) * | 2005-08-29 | 2009-03-05 | Ｔｔｉ・エルビュー株式会社 | センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置 |
| AU2006289888B2 (en) * | 2005-09-16 | 2010-12-02 | Tti Ellebeau, Inc. | Catheter type iontophoresis apparatus |
| US20070073212A1 (en) * | 2005-09-28 | 2007-03-29 | Takehiko Matsumura | Iontophoresis apparatus and method to deliver active agents to biological interfaces |
| US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
| JP4902543B2 (ja) * | 2005-09-30 | 2012-03-21 | Ｔｔｉ・エルビュー株式会社 | 形状記憶セパレータを有するイオントフォレーシス用電極構造体およびそれを用いたイオントフォレーシス装置 |
| JPWO2007037476A1 (ja) * | 2005-09-30 | 2009-04-16 | Ｔｔｉ・エルビュー株式会社 | 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置 |
| CN101277737A (zh) * | 2005-09-30 | 2008-10-01 | Tti优而美株式会社 | 将多种活性剂输送至生物界面的离子电渗装置 |
| US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
| US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
| WO2008087803A1 (ja) * | 2007-01-16 | 2008-07-24 | Hokkaido University | 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤 |
| JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
| RU2011113755A (ru) * | 2008-09-10 | 2012-10-20 | Транску Лтд. (Sg) | Устройство и способ для распределения вязких жидкостей на основе hpc в пористые субстраты, например, непрерывным ленточным способом |
| WO2010115015A1 (en) * | 2009-04-03 | 2010-10-07 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4983392A (en) * | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
| US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
| EP0199855A1 (en) * | 1985-05-02 | 1986-11-05 | Gist-Brocades N.V. | Tablets comprising tromethoprim and a sulfonamide |
| JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
| DE3740684A1 (de) * | 1987-12-01 | 1989-06-15 | Woehr Otto Gmbh | Parksystem |
| MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
| CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
-
1990
- 1990-12-07 SE SE9003903A patent/SE9003903D0/xx unknown
-
1991
- 1991-11-27 YU YU186791A patent/YU186791A/sh unknown
- 1991-11-28 IE IE413691A patent/IE914136A1/en not_active Application Discontinuation
- 1991-12-03 AT AT91920634T patent/ATE444737T1/de not_active IP Right Cessation
- 1991-12-03 JP JP50011692A patent/JP3276956B2/ja not_active Expired - Fee Related
- 1991-12-03 CA CA002097176A patent/CA2097176C/en not_active Expired - Fee Related
- 1991-12-03 EP EP91920634A patent/EP0560816B1/en not_active Expired - Lifetime
- 1991-12-03 WO PCT/SE1991/000814 patent/WO1992010171A1/en active Application Filing
- 1991-12-03 HU HU9301671A patent/HU218661B/hu not_active IP Right Cessation
- 1991-12-03 AU AU89305/91A patent/AU656346B2/en not_active Ceased
- 1991-12-03 DE DE69133623T patent/DE69133623D1/de not_active Expired - Fee Related
- 1991-12-04 US US07/802,325 patent/US5707656A/en not_active Expired - Lifetime
- 1991-12-06 IS IS3787A patent/IS1749B/is unknown
- 1991-12-06 PT PT99720A patent/PT99720B/pt active IP Right Grant
-
1993
- 1993-06-04 NO NO932053A patent/NO305536B1/no not_active IP Right Cessation
- 1993-06-04 FI FI932553A patent/FI932553A0/fi unknown
-
1994
- 1994-03-22 US US08/216,028 patent/US5709882A/en not_active Expired - Lifetime
- 1994-11-17 EE EE9400416A patent/EE03105B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU218661B (hu) | 2000-10-28 |
| JP3276956B2 (ja) | 2002-04-22 |
| CA2097176A1 (en) | 1992-06-08 |
| FI932553A (fi) | 1993-06-04 |
| EP0560816B1 (en) | 2009-10-07 |
| NO305536B1 (no) | 1999-06-21 |
| AU8930591A (en) | 1992-07-08 |
| SE9003903D0 (sv) | 1990-12-07 |
| IE914136A1 (en) | 1992-06-17 |
| DE69133623D1 (de) | 2009-11-19 |
| NO932053L (no) | 1993-07-20 |
| AU656346B2 (en) | 1995-02-02 |
| ATE444737T1 (de) | 2009-10-15 |
| IS1749B (is) | 2000-07-11 |
| IS3787A7 (is) | 1992-06-08 |
| JPH06503311A (ja) | 1994-04-14 |
| US5709882A (en) | 1998-01-20 |
| YU186791A (sh) | 1994-04-05 |
| US5707656A (en) | 1998-01-13 |
| EP0560816A1 (en) | 1993-09-22 |
| PT99720B (pt) | 2002-04-29 |
| WO1992010171A1 (en) | 1992-06-25 |
| NO932053D0 (no) | 1993-06-04 |
| EE03105B1 (et) | 1998-08-17 |
| CA2097176C (en) | 2002-03-26 |
| PT99720A (pt) | 1992-10-30 |
| HU9301671D0 (en) | 1993-09-28 |
| FI932553A0 (fi) | 1993-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT64213A (en) | Process for producing new medicament forms containing inoizable materials of medical affect | |
| GEP20063773B (en) | Steroid Sulphatase Inhibitors | |
| MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| ES8308216A1 (es) | "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento". | |
| FR2526443B1 (fr) | Activateur de plasminogene de tissu humain, son procede de production et composition pharmaceutique le contenant | |
| HU908477D0 (en) | Process for the production of medical preparations with controlled content of active agents | |
| MY105279A (en) | Transdermal therapeutic system comprising tulobuterol as active substance. | |
| HUP0004583A2 (hu) | Eljárás liposzómába zárt, taxán tartalmú gyógyszerkészítmény előállítására | |
| MY103741A (en) | Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process | |
| DK0957981T3 (da) | Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer | |
| ES510245A0 (es) | "un metodo para obtener una preparacion de insulina". | |
| GR78987B (hu) | ||
| HUT51596A (en) | Process for production of the active substance of the medical composition levodopa | |
| PT730871E (pt) | Complexo de quitosano radioactivo e sua utilizacao para terapeutica de radiacao | |
| CA2171124A1 (en) | A radioactive patch/film and process for preparation thereof | |
| DE59607949D1 (de) | Feste arzneimittelform mit polymerem material verteiltem wirkstoff | |
| HU886315D0 (en) | Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents | |
| UA33683A (uk) | Спосіб лікування поліпозного риносинуїту | |
| SU1637534A1 (ru) | Способ исследования системы кроветворения при летательном облучении | |
| PT80496A (en) | The novel physiologically active substance foroxymithine a process ane microorganisms for its production and its use as medicament | |
| RS49796B (sr) | UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA | |
| HU209365B (en) | Process for the production of a medicative preparation containing venom as an active agent | |
| HU913832D0 (en) | Process for the production of medical preparations in capsules, containing alcali-hydrogen-carbonates as active agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |